round button
Chat now

北美内镜逆行胰胆管造影设备市场 – 行业趋势及 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美内镜逆行胰胆管造影设备市场 – 行业趋势及 2028 年预测

  • Medical Devices
  • Published Report
  • Sep 2021
  • North America
  • 350 页面
  • 桌子數: 69
  • 图号: 48

North America Endoscopic Retrograde Cholangiopancreatography Devices Market

市场规模(十亿美元)

CAGR :  % Diagram

Chart Image USD 767.59 Million USD 1,179.01 Million 2021 2028
Diagram Forecast Period
2021 –2028
Diagram Market Size (Base Year)
USD 767.59 Million
Diagram Market Size (Forecast Year)
USD 1,179.01 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

北美内镜逆行胰胆管造影设备市场,按产品类型(内镜治疗设备、内窥镜、成像设备等)、方式(一次性使用、独立式、手持式)、程序(胆道括约肌切除术、胆道支架置入术、胆道扩张、胰管支架置入术、胰腺括约肌切除术)、应用(胆管、胰腺、胆囊、肝脏等)、最终用户(医院、门诊手术中心、诊断实验室等)、设施类型(大型、中型和小型)、分销渠道(直接招标、第三方分销和零售)、国家(美国、加拿大和墨西哥)行业趋势和预测 2028。

北美内镜逆行胰胆管造影设备市场市场分析与洞察:北美内镜逆行胰胆管造影设备市场 

北美内镜逆行胰胆管造影设备市场预计将在 2021 年至 2028 年的预测期内增长。Data Bridge Market Research 分析称,在 2021 年至 2028 年的预测期内,该市场将以 6.0% 的复合年增长率增长,预计到 2028 年将从 2020 年的 7.6759 亿美元达到 11.7901 亿美元。胰腺和胆道疾病的高患病率可能是预测期内推动市场需求的主要驱动力。

胰腺和胆道疾病的高发性、市场参与者的庞大数量以及先进技术设备的发展推动着市场的增长。FDA 制定的严格监管环境对市场起到了约束作用。先进的医疗基础设施、优惠的报销环境为市场提供了机遇。然而,技术人员的短缺可能对市场增长构成挑战。

北美内镜逆行胰胆管造影设备市场报告提供了市场份额、新发展和国内和本地市场参与者的影响的详细信息,分析了新兴收入来源、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况,请联系我们获取分析师简报。我们的团队将帮助您创建收入影响解决方案,以实现您的预​​期目标。

北美内镜逆行胰胆管造影设备市场北美内镜逆行胰胆管造影设备市场范围和市场规模

北美内镜逆行胰胆管造影设备市场根据产品类型、方式、程序、应用、最终用户、设施类型和分销渠道分为七个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

  • 根据产品类型,北美内镜逆行胰胆管造影设备市场细分为内镜治疗设备、内窥镜、成像设备和其他设备。2021 年,内镜治疗设备细分市场预计将占据市场主导地位,因为该细分市场拥有各种类型的设备,北美市场上有大型企业在制造此类设备。
  • 根据使用方式,北美内镜逆行胰胆管造影设备市场分为一次性、独立式和手持式。2021 年,一次性设备预计将占据市场主导地位,因为使用一次性设备时不存在疾病从一名患者传播给另一名患者的风险。
  • 根据手术方式,北美内镜逆行胰胆管造影设备市场细分为胆道括约肌切开术、胆道支架置入术、胆道扩张术、胰管支架置入术和胰腺括约肌切开术。由于北美地区胰腺肿瘤患病率高,预计 2021 年胆道括约肌切开术将占据市场主导地位。
  • 根据应用,北美内镜逆行胰胆管造影设备市场细分为胆管、胰腺、胆囊、肝脏和其他。由于北美地区胆道疾病患病率高,预计 2021 年胆管领域将占据市场主导地位。
  • 根据最终用户,北美内镜逆行胰胆管造影设备市场分为医院、门诊手术中心、诊断实验室和其他。2021 年,医院部门预计将占据市场主导地位,因为医疗器械公司越来越重视战略举措(例如收购、伙伴关系和合作),以扩大其在 ERCP 市场的能力。
  • 根据设施类型,北美内镜逆行胰胆管造影设备市场分为大型、中型和小型。由于北美对 ERCP 程序的需求很高,预计 2021 年大型设备将占据市场主导地位。
  • 根据分销渠道,北美内镜逆行胰胆管造影设备市场分为直接招标、第三方分销和零售。2021 年,直接招标部分预计将占据市场主导地位,因为直接招标部分对销售和收入流程有全面控制,并且与客户直接互动,因此增长显著。

北美内镜逆行胰胆管造影设备市场国家级分析

对北美内镜逆行胰胆管造影设备市场进行了分析,并按国家、产品类型、方式、程序、应用、最终用户、设施类型和分销渠道提供了市场规模信息。

北美内镜逆行胰胆管造影设备市场报告涵盖的国家包括美国、加拿大和墨西哥。

北美预计将在市场上占据主导地位,就像北美国家一样;随着医疗保健基础设施的不断增加,对 ERCP 设备的需求正在迅速增加。美国预计将在北美市场占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。 

先进技术的存在和参与者采取的战略举措正在为北美内镜逆行胰胆管造影设备 市场  创造新的机遇

北美内镜逆行胰胆管造影设备市场还为您提供每个国家/地区特定行业增长的详细市场分析,包括 ERCP 产品销售、市场发展的影响以及监管环境的变化及其对市场的支持。数据涵盖 2010 年至 2019 年的历史时期。

竞争格局和欧洲内镜逆行胰胆管造影设备市场份额分析

北美内镜逆行胰胆管造影设备市场竞争格局提供竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上数据点仅与公司对内镜逆行胰胆管造影设备市场的关注有关。

北美主要的内镜逆行胰胆管造影设备供应商有:奥林巴斯公司、波士顿科学公司、美敦力公司、BD、Ambu 公司、CONMED 公司、HOBBS MEDICAL 公司、FUJIFILM 公司、TeleMed Systems 公司、Merit Medical Systems 公司、Cook 公司、KARL STORZ SE & Co. KG 公司、强生服务公司、HOYA 公司、STERIS 公司、Shaili Endoscopy 公司等。

DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

市场参与者的战略举措和内镜逆行胰胆管造影设备的新技术进步正在弥合各种治疗之间的差距。

例如,

  • 2020 年 7 月,Ambu Inc. 宣布其无菌一次性十二指肠镜 Ambu aScope Duodeno 已获得 FDA 批准。这有助于该公司在未来几年扩大业务。
  • 2021 年 1 月,CONMED Corporation 将出席摩根大通虚拟医疗保健会议。会议旨在向客户提供有关其产品的正确知识。这次会议促进了市场增长并有助于创收。

市场参与者的合作、合资和其他策略正在增强公司在内镜逆行胰胆管造影设备市场的市场,这也有利于该组织改善其对市场的供应。

 

 


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEAR CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGIONAL SUMMARY

5.1 NORTH AMERICA

5.2 EUROPE

5.3 ASIA-PACIFIC

5.4 SOUTH AMERICA

5.5 MIDDLE EAST AND AFRICA

6 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGULATIONS

6.1 UNITED STATES

6.2 EUROPE

6.3 CHINA

6.4 AUSTRALIA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 SURGE IN PREVALENCE OF PANCREATIC AND LIVER DISORDERS

7.1.2 INCREASE IN THE GERIATRIC POPULATION

7.1.3 RISING HEALTHCARE EXPENDITURE

7.1.4 HIGH PREVALENCE OF PANCREATIC CANCER

7.2 RESTRAINTS

7.2.1 HIGH COST OF DEVICES

7.2.2 STRINGENT GOVERNMENT RULES

7.2.3 EMERGENCE OF COVID-19

7.3 OPPORTUNITIES

7.3.1 STRATEGIC INITIATIVES TAKEN BY PLAYERS

7.3.2 RISE IN ALCOHOL CONSUMPTION AND SURGE IN SMOKING

7.3.3 RISING DISPOSABLE INCOME

7.3.4 GROWING MEDICAL TOURISM

7.4 CHALLENGES

7.4.1 COMPLICATIONS ASSOCIATED WITH PROCEDURE

7.4.2 SHORTAGE OF SKILLED PERSONNEL

8 IMPACT OF COVID-19 ON NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET

8.1 IMPACT ON PRICE

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY

8.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID 19

8.5 CONCLUSION:

9 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE

9.1 OVERVIEW

9.2 ENDOTHERAPY DEVICES

9.2.1 SPHINCTEROTOME

9.2.2 CANNULAS

9.2.3 CATHETERS

9.2.4 BALLOONS

9.2.5 LITHOTRIPTERS

9.2.6 STENTS

9.2.7 GUIDING WIRES

9.2.8 FORCEPS

9.2.9 BASKETS

9.2.10 SNARES

9.2.11 OTHERS

9.3 ENDOSCOPE

9.4 IMAGING DEVICES

9.5 OTHERS

10 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY

10.1 OVERVIEW

10.2 SINGLE USE

10.3 STANDALONE

10.4 HANDHELD

11 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE

11.1 OVERVIEW

11.2 BILIARY SPHINCTERECTOMY

11.3 BILIARY STENTING

11.4 BILIARY DILATION

11.5 PANCREATIC DUCT STENTING

11.6 PANCREATIC DUCT DILATION

11.7 PANCREATIC SPHINCTERECTOMY

12 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 BILE DUCT

12.3 PANCREAS

12.4 GALL BLADDER

12.5 LIVER

12.6 OTHERS

13 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.3 AMBULATORY SURGICAL CENTERS

13.4 DIAGNOSTIC LABORATORIES

13.5 OTHERS

14 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE

14.1 OVERVIEW

14.2 LARGE

14.3 MEDIUM

14.4 SMALL

15 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 DIRECT TENDERS

15.3 THIRD PARTY DISTRIBUTION

15.4 RETAIL SALES

16 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION

16.1 NORTH AMERICA

16.1.1 U.S.

16.1.2 CANADA

16.1.3 MEXICO

17 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

18 SWOT ANALYSIS

19 COMPANY PROFILE

19.1 OLYMPUS CORPORATION

19.1.1 COMPANY SNAPSHOT

19.1.2 REVENUE ANALYSIS

19.1.3 COMPANY SHARE ANALYSIS

19.1.4 PRODUCT PORTFOLIO

19.1.5 RECENT DEVELOPMENTS

19.2 BOSTON SCIENTIFIC CORPORATION

19.2.1 COMPANY SNAPSHOT

19.2.2 REVENUE ANALYSIS

19.2.3 COMPANY SHARE ANALYSIS

19.2.4 PRODUCT PORTFOLIO

19.2.5 RECENT DEVELOPMENTS

19.3 STERIS

19.3.1 COMPANY SNAPSHOT

19.3.2 REVENUE ANALYSIS

19.3.3 COMPANY SHARE ANALYSIS

19.3.4 PRODUCT PORTFOLIO

19.3.5 RECENT DEVELOPMENTS

19.4 FUJIFILM CORPORATION

19.4.1 COMPANY SNAPSHOT

19.4.2 REVENUE ANALYSIS

19.4.3 COMPANY SHARE ANALYSIS

19.4.4 PRODUCT PORTFOLIO

19.4.5 RECENT DEVELOPMENTS

19.5 BD

19.5.1 COMPANY SNAPSHOT

19.5.2 REVENUE ANALYSIS

19.5.3 COMPANY SHARE ANALYSIS

19.5.4 PRODUCT PORTFOLIO

19.5.5 RECENT DEVELOPMENTS

19.6 MEDTRONIC

19.6.1 COMPANY SNAPSHOT

19.6.2 REVENUE ANALYSIS

19.6.3 PRODUCT PORTFOLIO

19.6.4 RECENT DEVELOPMENTS

19.7 JOHNSON & JOHNSON SERVICES, INC.

19.7.1 COMPANY SNAPSHOT

19.7.2 REVENUE ANALYSIS

19.7.3 PRODUCT PORTFOLIO

19.7.4 RECENT DEVELOPMENTS

19.8 AMBU INC.

19.8.1 COMPANY SNAPSHOT

19.8.2 REVENUE ANALYSIS

19.8.3 PRODUCT PORTFOLIO

19.8.4 RECENT DEVELOPMENTS

19.9 CONMED CORPORATION

19.9.1 COMPANY SNAPSHOT

19.9.2 REVENUE ANALYSIS

19.9.3 PRODUCT PORTFOLIO

19.9.4 RECENT DEVELOPMENTS

19.1 COOK

19.10.1 COMPANY SNAPSHOT

19.10.2 PRODUCT PORTFOLIO

19.10.3 RECENT DEVELOPMENT

19.11 HOBBS MEDICAL INC.

19.11.1 COMPANY SNAPSHOT

19.11.2 PRODUCT PORTFOLIO

19.11.3 RECENT DEVELOPMENT

19.12 HOSPILINE EQUIPMENTS

19.12.1 COMPANY SNAPSHOT

19.12.2 PRODUCT PORTFOLIO

19.12.3 RECENT DEVELOPMENT

19.13 HOYA CORPORATION

19.13.1 COMPANY SNAPSHOT

19.13.2 REVENUE ANALYSIS

19.13.3 PRODUCT PORTFOLIO

19.13.4 RECENT DEVELOPMENT

19.14 KARL STORZ SE & CO. KG

19.14.1 COMPANY SNAPSHOT

19.14.2 PRODUCT PORTFOLIO

19.14.3 RECENT DEVELOPMENTS

19.15 MEDI-GLOBE GMBH

19.15.1 COMPANY SNAPSHOT

19.15.2 PRODUCT PORTFOLIO

19.15.3 RECENT DEVELOPMENT

19.16 MERIT MEDICAL SYSTEMS

19.16.1 COMPANY SNAPSHOT

19.16.2 REVENUE ANALYSIS

19.16.3 PRODUCT PORTFOLIO

19.16.4 RECENT DEVELOPMENT

19.17 SHAILI ENDOSCOPY

19.17.1 COMPANY SNAPSHOT

19.17.2 PRODUCT PORTFOLIO

19.17.3 RECENT DEVELOPMENT

19.18 TELEMED SYSTEMS, INC.

19.18.1 COMPANY SNAPSHOT

19.18.2 PRODUCT PORTFOLIO

19.18.3 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORTS

表格列表

TABLE 1 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 2 NORTH AMERICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA ENDOSCOPE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA IMAGING DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA SINGLE USE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA STANDALONE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA HANDHELD IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA BILIARY SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA BILIARY STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA BILIARY DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA PANCREATIC DUCT STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA PANCREATIC DUCT DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA PANCREATIC SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA BILE DUCT IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA PANCREAS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA GALL BLADDER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA LIVER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA HOSPITALS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA DIAGNOSTIC LABORATORIES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA LARGE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA MEDIUM IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA SMALL IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA DIRECT TENDERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA THIRD PARTY DISTRIBUTION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA RETAIL SALES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 46 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 47 U.S. ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 48 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 49 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 50 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 51 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 53 U.S. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 54 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 55 CANADA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 56 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 57 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 58 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 61 CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 62 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 63 MEXICO ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 64 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 65 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 66 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 68 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)

TABLE 69 MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION

FIGURE 11 THE HIGH PREVALENCE OF PANCREATIC AND BILIARY DISEASES IS EXPECTED TO DRIVE THE NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 ENDOTHERAPY DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET

FIGURE 14 PANCREATIC CANCER MORTALITY, BY REGION (2020)

FIGURE 15 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2020

FIGURE 16 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)

FIGURE 17 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2021-2028)

FIGURE 18 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 19 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2020

FIGURE 20 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 21 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 22 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 23 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2020

FIGURE 24 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2021-2028 (USD MILLION)

FIGURE 25 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)

FIGURE 26 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE

FIGURE 27 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2020

FIGURE 28 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 29 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 30 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 31 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2020

FIGURE 32 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 33 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, CAGR (2021-2028)

FIGURE 34 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2020

FIGURE 36 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2021-2028 (USD MILLION)

FIGURE 37 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, CAGR (2021-2028)

FIGURE 38 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, LIFELINE CURVE

FIGURE 39 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 40 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 41 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 42 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 43 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SNAPSHOT (2020)

FIGURE 44 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020)

FIGURE 45 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 46 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 48 NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY SHARE 2020 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

The North America endoscopic retrograde cholangiopancreatography devices market size will be worth USD 1,179.01 million by 2028.
The growth rate of the North America endoscopic retrograde cholangiopancreatography devices market is 6.0%.
Latest developments in the North America endoscopic retrograde cholangiopancreatography devices market are - Ambu Inc. announced that it has received FDA approval for sterile, single use duodenoscope, Ambu aScope Duodeno & CONMED Corporation to present at the J.P. Morgan Virtual Healthcare Conference.
Product type, modality, procedure, application, end user, facility type, and distribution channel are the factors on which the North America endoscopic retrograde cholangiopancreatography devices market research is based.
Major companies in the North America endoscopic retrograde cholangiopancreatography devices market are Olympus Corporation, Boston Scientific Corporation, Medtronic, BD, Ambu Inc., CONMED Corporation, HOBBS MEDICAL, INC., FUJIFILM Corporation, TeleMed Systems, Inc., Merit Medical Systems, Cook, KARL STORZ SE & Co. KG, Johnson & Johnson Services, Inc., HOYA Corporation, STERIS, Shaili Endoscopy, among others.
Testimonial
a